Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhakti Umesh Hirlekar

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Medicinal Chemistry|March 29, 2023
An overview of compound properties, multiparameter optimization, and computational drug design methods for PARP-1 inhibitor drugsBhakti Umesh Hirlekar, Anila Nuthi, Krishan Dev Singh, et al.
Molecular Diversity|February 20, 2024
Improved QSAR models for PARP-1 inhibition using data balancing, interpretable machine learning, and matched molecular pair analysisAnish Gomatam, Bhakti Umesh Hirlekar, Krishan Dev Singh, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 12, 2023
In vitro, in-vivo, and in-silico investigation of physicochemical interactions between pioglitazone and rifampicinOmkar Londhe, Sayalee Sanjay Mane, Bhakti Umesh Hirlekar, et al.
Natural Product Research|February 7, 2022
Isolation of phytochemicals from <i>Dolichandrone atrovirens</i> followed by semisynthetic modification of ixoside via azomethine ylide cycloaddition; computational approach towards chemo-selectionMeenakshi Singh, Bhakti Umesh Hirlekar, Shagufta Mondal, et al.
Drug Testing and Analysis|October 7, 2021
Analytical developments of p-hydroxy prenylamine reference material for dope control research: Characterization and purity assessmentAthira Joseph, Gangasani Jagadeesh Kumar, Sachin Dattram Pawar, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Medicinal Chemistry|March 29, 2023
An overview of compound properties, multiparameter optimization, and computational drug design methods for PARP-1 inhibitor drugsBhakti Umesh Hirlekar, Anila Nuthi, Krishan Dev Singh, et al.
Molecular Diversity|February 20, 2024
Improved QSAR models for PARP-1 inhibition using data balancing, interpretable machine learning, and matched molecular pair analysisAnish Gomatam, Bhakti Umesh Hirlekar, Krishan Dev Singh, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 12, 2023
In vitro, in-vivo, and in-silico investigation of physicochemical interactions between pioglitazone and rifampicinOmkar Londhe, Sayalee Sanjay Mane, Bhakti Umesh Hirlekar, et al.
Natural Product Research|February 7, 2022
Isolation of phytochemicals from <i>Dolichandrone atrovirens</i> followed by semisynthetic modification of ixoside via azomethine ylide cycloaddition; computational approach towards chemo-selectionMeenakshi Singh, Bhakti Umesh Hirlekar, Shagufta Mondal, et al.
Drug Testing and Analysis|October 7, 2021
Analytical developments of p-hydroxy prenylamine reference material for dope control research: Characterization and purity assessmentAthira Joseph, Gangasani Jagadeesh Kumar, Sachin Dattram Pawar, et al.
Pageof 1